Advertisement
Screener

Clene Inc. (CLNN) Beta

Clene Inc. (CLNN) Beta

  • Beta · 5-year monthly: Value 0.97; Formula and calculation Saved five-year monthly beta; measures historical sensitivity to the benchmark..

Beta

Overview →

Financial period ending 2026-08-31; current quote 2026-08-31. Amounts retain their stated periods and units.

MetricValueFormula and calculation
Beta · 5-year monthly0.97Saved five-year monthly beta; measures historical sensitivity to the benchmark.

Calculated history

Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.

Period endingBeta
2026-08-310.97

(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.

Similar stocks

Stock NameCountryMarket CapPE Ratio
Serina Therapeutics, Inc. (SER)United States$0.054B-2.35
HERON THERAPEUTICS, INC. /DE/ (HRTX)United States$0.055B-2.38
Annovis Bio, Inc. (ANVS)United States$0.056B-1.58
Xilio Therapeutics, Inc. (XLO)United States$0.052B
NOMAD POWER SOLUTIONS, INC. (NMAD)United States$0.058B
Boundless Bio, Inc. (BOLD)United States$0.059B-0.88
Elicio Therapeutics, Inc. (ELTX)United States$0.049B
Lite Strategy, Inc. (LITS)United States$0.049B
Dogwood Therapeutics, Inc. (DWTX)United States$0.049B
TALPHERA, INC. (TLPH)United States$0.060B